MedGenome invites you to a webinar on
Utility and Best Practices in NIPT
Summary of the Talk
Non-invasive prenatal testing (NIPT) is one of the best methods of screening for aneuploidies in the fetus, prenatally. The technique is know to be highly reliable and accurate in aneuploidy detection. It has also seen increased adoption in India because of better understanding and increased awareness about the availability of the test.
This webinar will focus on the clinical utility of NIPT and look at some of recent discussion points including expanded screening. As an early laboratory adopter and with an experience of processing thousands of samples across platforms, best practices for a successful test will be discussed.
Dr. Priya Kadam
Associate Director- Reproductive Genomics, MedGenome Labs
Dr. Priya Kadam heads and oversees the NIPT clinical reporting at Medgenome. She has a Master of Science by research from National University of Singapore and an MBBS from Bangalore Medical College. She has filed for patents in US and China for her work on prenatal testing. Her work has been published in journals such Journal of Proteomics, Cancer Biology and Therapy among others..
Dr. E Venkatswamy,
Associate Director-Quality Assurance, MedGenome Labs
Dr. E. Venkataswamy has a Ph.D in Human Genetics (2003-2008), from National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore. He has over 10 peer-reviewed publications to his credit and many abstracts published in various conferences and workshops. Dr. Venkat manages Non-invasive prenatal testing (NIPT), Pre-implantation Genetic testing (PGS and PGD) and Fluorescence in-situ hybridisation at MedGenome Lab.